| 2022-12-01 |
复牌提示：
2022-11-30 19:50:00 停牌，复牌日期 2022-12-02 00:00:01
|
| 2022-11-30 |
详情>>
内部人交易：
HURWITZ EDWARD等共交易9笔
|
| 2022-11-21 |
详情>>
股本变动：
变动后总股本6763.22万股
|
| 2022-11-21 |
详情>>
业绩披露：
2023年一季报每股收益-0.28美元,归母净利润-1841万美元,同比去年增长-7.54%
|
| 2022-09-27 |
详情>>
业绩披露：
2022年年报每股收益-1.53美元,归母净利润-6894.3万美元,同比去年增长-19.22%
|
| 2022-05-16 |
详情>>
业绩披露：
2022年三季报(累计)每股收益-1.17美元,归母净利润-5055.7万美元,同比去年增长-10.64%
|
| 2022-02-14 |
详情>>
业绩披露：
2022年中报每股收益-0.85美元,归母净利润-3626.3万美元,同比去年增长-17.58%
|
| 2022-02-14 |
财报披露：
美东时间 2022-02-14 盘前发布财报
|
| 2021-11-09 |
详情>>
业绩披露：
2022年一季报每股收益-0.4美元,归母净利润-1711.9万美元,同比去年增长-11.31%
|
| 2021-10-15 |
股东大会：
将于2021-11-30召开股东大会
会议内容 ▼▲
- 1.re-elect as our Class II directors each of Scott Koenig, Yehia Hashad and Ivana Magovcevic-Liebisch, each to serve for a three-year term ending at our 2025 annual meeting of stockholders;
2.approve, on an advisory basis, the compensation paid to our named executive officers, as disclosed in this proxy statement;
3.ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending June 30, 2022;
4.consider any other business properly presented at the meeting.
|
| 2021-09-23 |
详情>>
业绩披露：
2021年年报每股收益-1.77美元,归母净利润-5782.9万美元,同比去年增长-26.01%
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-05-17 |
详情>>
业绩披露：
2021年三季报(累计)每股收益-1.55美元,归母净利润-4569.3万美元,同比去年增长-45.57%
|
| 2021-02-11 |
详情>>
业绩披露：
2021年中报每股收益-1.19美元,归母净利润-3084.2万美元,同比去年增长-52.68%
|
| 2020-11-16 |
详情>>
业绩披露：
2021年一季报每股收益-0.6美元,归母净利润-1538万美元,同比去年增长-32.85%
|
| 2020-11-02 |
股东大会：
将于2020-12-16召开股东大会
会议内容 ▼▲
- 1.re-elect as our Class I directors William Aliski and Anne VanLent, each to serve for a three-year term ending at our 2024 annual meeting of stockholders;
2.approve, on an advisory basis, the compensation paid to our named executive officers, as disclosed in this proxy statement;
3.ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending June 30, 2021;
4.consider any other business properly presented at the meeting.
|
| 2020-09-18 |
详情>>
业绩披露：
2020年年报每股收益-2.17美元,归母净利润-4589.2万美元,同比去年增长-2187.74%
|
| 2019-11-04 |
股东大会：
将于2019-12-04召开股东大会
会议内容 ▼▲
- 1.re-elect as our Class III directors Susan B. Washer, Ed Hurwitz and James Rosen, each to serve for a three-year term ending at our 2023 annual meeting of stockholders;
2.approve, on an advisory basis, the compensation paid to our named executive officers, as disclosed in this proxy statement;
3.approve, on an advisory basis, the frequency of holding an advisory vote on the compensation paid to our named executive officers;
4.ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for fiscal year 2020;
5.consider any other business properly presented at the meeting.
|
| 2018-10-16 |
股东大会：
将于2018-11-15召开股东大会
会议内容 ▼▲
- 1.re-elect as our Class II directors Scott Koenig and Ivana Magovcevic-Liebisch, each to serve for a three-year term ending at our 2022 annual meeting of stockholders;
2.ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for fiscal year 2019;
3.consider any other business properly presented at the meeting.
|
| 2018-01-29 |
股东大会：
将于2018-02-28召开股东大会
会议内容 ▼▲
- 1.re-elect as our Class I director Anne Van Lent, to serve for a three-year term ending at our 2021 annual meeting of stockholders;
2.ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for fiscal year 2018;
3.consider any other business properly presented at the meeting.
|
| 2017-01-13 |
股东大会：
将于2017-02-28召开股东大会
会议内容 ▼▲
- 1.the re-election as our class III directors Susan B. Washer, Ed Hurwitz and James Rosen, each to serve for a three-year term ending at our 2020 annual meeting of stockholders;
2.the ratification of the appointment of RSM US LLP as our independent registered public accounting firm for our fiscal year ending on June 30, 2017;
3.any other business properly presented at the meeting.
|
| 2015-10-13 |
股东大会：
将于2015-11-19召开股东大会
会议内容 ▼▲
- 1.re-elect as our class II directors Scott Koenig, M.D., Ph.D. and Ivana Magovcevic-Liebisch, Ph.D., each to serve for a three-year term ending at our 2018 annual meeting of stockholders;
2.ratify the appointment of McGladrey LLP as our independent registered public accounting firm for fiscal year 2016;
3.consider any other business properly presented at the meeting.
|
| 2014-10-10 |
股东大会：
将于2014-11-19召开股东大会
会议内容 ▼▲
- 1.Re-elect as the company's class I directors David R. Guyer, M.D. and Arnold L. Oronsky, Ph.D., each to serve for a three-year term ending at the company's 2017 annual meeting of stockholders;
2.Ratify the appointment of McGladrey LLP as the company's independent registered public accounting firm for fiscal year 2015;
3.Consider any other business properly presented at the meeting.
|